Cargando…
TERT mutations-associated alterations in clinical characteristics, immune environment and therapy response in glioblastomas
OBJECTIVE TERT: is the most frequently mutated gene in adult glioblastomas (GBMs) defined by the 2021 World Health Organization classification system. The present study aims to explore differences in clinical characteristics and immune microenvironment between TERT mutant and wild-type GBM. METHODS:...
Autores principales: | Tang, Feng, Chen, Xi, Liu, Jin-Sheng, Liu, Zhen-Yuan, Yang, Jin-Zhou, Wang, Ze-Fen, Li, Zhi-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421840/ https://www.ncbi.nlm.nih.gov/pubmed/37566174 http://dx.doi.org/10.1007/s12672-023-00760-w |
Ejemplares similares
-
TERT Promoter Alterations in Glioblastoma: A Systematic Review
por: Olympios, Nathalie, et al.
Publicado: (2021) -
TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015) -
Prognostic Impact of the Combination of
MGMT
Methylation and
TERT
Promoter Mutation in Glioblastoma
por: Tunthanathip, Thara, et al.
Publicado: (2021) -
Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma
por: Lee, Hye Won, et al.
Publicado: (2017) -
ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma
por: Liu, Zhen-Yuan, et al.
Publicado: (2023)